Article
Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
CNS drugs - 1 Oct 2016
Xiao Tingting, Jiao Bin, Zhang Weiwei, Tang Beisha, Shen Lu
Abstract excerpt
BACKGROUND: Differential responses to donepezil treatment in patients with Alzheimer's disease (AD) have been observed in clinical practice. It remains controversial whether, and to what extent, individual variation in the genes responsible for drug metabolism (CYP2D6) or those associated with AD pathogenesis (APOE) modulate the response to donepezil treatment. OBJECTIVE: The aim of this study was to better...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
